Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 12032296)

1.

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.

Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7408-13.

2.

Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.

Ni J, Chen M, Zhang Y, Li R, Huang J, Yeh S.

Biochem Biophys Res Commun. 2003 Jan 10;300(2):357-63.

PMID:
12504091
3.
4.

Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.

Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S.

Asian J Androl. 2007 Jan;9(1):31-9.

5.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
6.
7.

Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.

Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP.

Cancer Res. 2000 Oct 1;60(19):5494-8.

8.

Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.

Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T.

J Urol. 2000 Sep;164(3 Pt 1):800-5.

PMID:
10953159
9.
11.

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL.

Prostate. 2005 Sep 1;64(4):362-72.

PMID:
15754350
12.

Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.

Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C.

J Biol Chem. 2004 Aug 6;279(32):33438-46. Epub 2004 May 27.

13.

In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.

Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS.

Cancer. 1996 May 1;77(9):1862-72.

PMID:
8646686
14.
15.
16.

RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.

Zhang M, Altuwaijri S, Yeh S.

Oncogene. 2004 Apr 15;23(17):3080-8.

PMID:
15048090
17.

Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.

Mashima T, Okabe S, Seimiya H.

Mol Pharmacol. 2010 Nov;78(5):846-54. doi: 10.1124/mol.110.064790. Epub 2010 Aug 13.

18.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk